Your browser doesn't support javascript.
loading
Prevalence, Features, and Prognostic Importance of Edge Dissection After Drug-Eluting Stent Implantation: An ADAPT-DES Intravascular Ultrasound Substudy.
Kobayashi, Nobuaki; Mintz, Gary S; Witzenbichler, Bernhard; Metzger, D Christopher; Rinaldi, Michael J; Duffy, Peter L; Weisz, Giora; Stuckey, Thomas D; Brodie, Bruce R; Parvataneni, Rupa; Kirtane, Ajay J; Stone, Gregg W; Maehara, Akiko.
Afiliação
  • Kobayashi N; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Mintz GS; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Witzenbichler B; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Metzger DC; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Rinaldi MJ; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Duffy PL; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Weisz G; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Stuckey TD; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Brodie BR; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Parvataneni R; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Kirtane AJ; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Stone GW; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
  • Maehara A; From the Clinical Trials Center, Cardiovascular Research Foundation, New York, NY (N.K., G.S.M., G.W., R.P., A.J.K., G.W.S., A.M.); NewYork-Presbyterian Hospital/Columbia University Medical Center (N.K., G.W., A.J.K., G.W.S., A.M.); Helios Amper-Klinikum, Dachau, Germany (B.W.); Wellmont CVA Heart I
Circ Cardiovasc Interv ; 9(7): e003553, 2016 07.
Article em En | MEDLINE | ID: mdl-27402854

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aneurisma Coronário / Doença da Artéria Coronariana / Ultrassonografia de Intervenção / Vasos Coronários / Stents Farmacológicos / Intervenção Coronária Percutânea / Dissecção Aórtica Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Aneurisma Coronário / Doença da Artéria Coronariana / Ultrassonografia de Intervenção / Vasos Coronários / Stents Farmacológicos / Intervenção Coronária Percutânea / Dissecção Aórtica Tipo de estudo: Clinical_trials / Etiology_studies / Observational_studies / Prevalence_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Circ Cardiovasc Interv Assunto da revista: ANGIOLOGIA / CARDIOLOGIA Ano de publicação: 2016 Tipo de documento: Article